Skip Navigation

Research

Global Projects

Map

Thymidylate Synthase (TS) Genotype-Directed Phase II Trial of Oral Capecitabine for 2nd-Line Treatment of Advanced Pancreatic Cancer

Madrid, Spain


Summary

To determine whether pre-selecting pancreatic cancer patients based on genotype will improve the activity of capecitabine in this disease.The study will be conducted a the Hospital "12deOctubre", Madrid. Dr. Manuel Hidalgo (Hopkins GI program co-Director) is setting up the trial in Spain. The principal investigator in Spain will be Carlos Gomez Martin, MD.

Locations

Centers